Core Viewpoint - The company anticipates a decline in demand for its animal health products due to a slowdown in China's livestock industry, but expects overall profit growth for the fiscal year 2025 [1] Group 1: Financial Performance - The company projects a shareholder's net profit of approximately $32 million for the year ending December 31, 2025, a significant increase from $11.2 million for the year ending December 31, 2024 [1] - The profit growth is primarily attributed to a substantial increase in revenue, reflecting the successful implementation of a key strategy focused on developing large customer sales [1] Group 2: Revenue Expectations - The company's quarterly revenue for the three months ending December 31, 2025, is expected to remain at a similar level to that of the three months ending September 30, 2025 [1]
正大企业国际发盈喜，预期2025年净利润约3200万美元